255 related articles for article (PubMed ID: 32295556)
1. Effect of epidermal growth factor ointment on persistent epithelial defects of the cornea.
Moon HS; Li L; Yoon HJ; Ji YS; Yoon KC
BMC Ophthalmol; 2020 Apr; 20(1):147. PubMed ID: 32295556
[TBL] [Abstract][Full Text] [Related]
2. Treatment of corneal defects with delayed re-epithelization with a medical device/drug delivery system for epidermal growth factor.
Holland S; Morck D; Schultz C
Clin Exp Ophthalmol; 2012; 40(7):662-8. PubMed ID: 22429860
[TBL] [Abstract][Full Text] [Related]
3. Open clinical study of eye-drops containing tetrapeptides derived from substance P and insulin-like growth factor-1 for treatment of persistent corneal epithelial defects associated with neurotrophic keratopathy.
Yamada N; Matsuda R; Morishige N; Yanai R; Chikama TI; Nishida T; Ishimitsu T; Kamiya A
Br J Ophthalmol; 2008 Jul; 92(7):896-900. PubMed ID: 18511539
[TBL] [Abstract][Full Text] [Related]
4. Topical insulin for refractory persistent corneal epithelial defects.
Abdi P; Ghaffari R; Azad N; Alshaheeb A; Latifi G; Soltani Shahgoli S; Fakhredin H
Sci Rep; 2024 May; 14(1):12459. PubMed ID: 38816428
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Autologous Serum Gel in Neurotrophic Persistent Corneal Epithelial Defects Combined with Lagophthalmos.
Kim HJ; Youn HC; Hyun JJ; Kim SW
Ophthalmol Ther; 2022 Dec; 11(6):2129-2139. PubMed ID: 36152214
[TBL] [Abstract][Full Text] [Related]
6. Allogenic simple limbal epithelial transplantation (alloSLET) from cadaveric donor eyes in patients with persistent corneal epithelial defects.
Riedl JC; Musayeva A; Wasielica-Poslednik J; Pfeiffer N; Gericke A
Br J Ophthalmol; 2021 Feb; 105(2):180-185. PubMed ID: 32327416
[TBL] [Abstract][Full Text] [Related]
7. Effect of topical administration of epidermal growth factor on healing of corneal epithelial defects in horses.
Burling K; Seguin MA; Marsh P; Brinkman K; Madigan J; Thurmond M; Moon-Massat P; Mannis M; Murphy CJ
Am J Vet Res; 2000 Sep; 61(9):1150-5. PubMed ID: 10976751
[TBL] [Abstract][Full Text] [Related]
8. Open clinical study of eye drops containing the fibronectin-derived peptide PHSRN for treatment of persistent corneal epithelial defects.
Yamada N; Morishige N; Yanai R; Morita Y; Kimura K; Chikama T; Nomizu M; Sonoda KH; Nishida T
Cornea; 2012 Dec; 31(12):1408-13. PubMed ID: 23135532
[TBL] [Abstract][Full Text] [Related]
9. Treatment of persistent corneal epithelial defect with extended wear of a fluid-ventilated gas-permeable scleral contact lens.
Rosenthal P; Cotter JM; Baum J
Am J Ophthalmol; 2000 Jul; 130(1):33-41. PubMed ID: 11004257
[TBL] [Abstract][Full Text] [Related]
10. Topical insulin for refractory persistent corneal epithelial defects.
Diaz-Valle D; Burgos-Blasco B; Gegundez-Fernandez JA; Garcia-Caride S; Puebla-Garcia V; Peña-Urbina P; Benitez-Del-Castillo JM
Eur J Ophthalmol; 2021 Sep; 31(5):2280-2286. PubMed ID: 32951459
[TBL] [Abstract][Full Text] [Related]
11. Effect of erythropoietin on healing of corneal epithelial defects in rabbits.
Livny E; Livnat T; Yakimov M; Masoud M; Weinberger D; Bahar I
Ophthalmic Res; 2013; 50(2):129-33. PubMed ID: 23941990
[TBL] [Abstract][Full Text] [Related]
12. Controlled-release of epidermal growth factor from cationized gelatin hydrogel enhances corneal epithelial wound healing.
Hori K; Sotozono C; Hamuro J; Yamasaki K; Kimura Y; Ozeki M; Tabata Y; Kinoshita S
J Control Release; 2007 Apr; 118(2):169-76. PubMed ID: 17289206
[TBL] [Abstract][Full Text] [Related]
13. [Topical application of EGF for the therapy of persisting corneal erosion under cetuximab treatment].
Förster CG; Cursiefen C; Kruse FE
Ophthalmologe; 2008 Mar; 105(3):269-73. PubMed ID: 18350301
[TBL] [Abstract][Full Text] [Related]
14. Autologous serum 50% eyedrops in the treatment of persistent corneal epithelial defects.
Jeng BH; Dupps WJ
Cornea; 2009 Dec; 28(10):1104-8. PubMed ID: 19730088
[TBL] [Abstract][Full Text] [Related]
15. A study of refractory cases of persistent epithelial defects associated with dry eye syndrome and recurrent corneal erosions successfully treated with cyclosporine A 0.05% eye drops.
Napoli PE; Braghiroli M; Iovino C; Demarinis G; Fossarello M
Drug Des Devel Ther; 2019; 13():2001-2008. PubMed ID: 31354245
[No Abstract] [Full Text] [Related]
16. Amniotic Membrane Transplantation in Acute Severe Ocular Chemical Injury: A Randomized Clinical Trial.
Eslani M; Baradaran-Rafii A; Cheung AY; Kurji KH; Hasani H; Djalilian AR; Holland EJ
Am J Ophthalmol; 2019 Mar; 199():209-215. PubMed ID: 30419194
[TBL] [Abstract][Full Text] [Related]
17. Outcomes and success of amniotic membrane transplantation for the treatment of corneal diseases.
Dikmetas O; Kapucu Y; Cankaya AB; Kocabeyoglu S
Cutan Ocul Toxicol; 2024 Mar; 43(1):33-37. PubMed ID: 37879107
[TBL] [Abstract][Full Text] [Related]
18. Persistent epithelial defects due to neurotrophic keratopathy treated with a substance p-derived peptide and insulin-like growth factor 1.
Nishida T; Chikama T; Morishige N; Yanai R; Yamada N; Saito J
Jpn J Ophthalmol; 2007; 51(6):442-7. PubMed ID: 18158595
[TBL] [Abstract][Full Text] [Related]
19. Healing rate of corneal erosions: comparison of the effect of chloramphenicol eye drops and ointment and high-concentration hyaluronic acid in an animal model.
Barequet IS; Harizman N; Ziv H; Rosner M
Cornea; 2014 Oct; 33(10):1080-2. PubMed ID: 25119960
[TBL] [Abstract][Full Text] [Related]
20. Effect of autologous platelet-rich plasma on persistent corneal epithelial defect after infectious keratitis.
Kim KM; Shin YT; Kim HK
Jpn J Ophthalmol; 2012 Nov; 56(6):544-50. PubMed ID: 22972393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
